ATL001

· Achilles Therapeutics UK Limited

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ATL001, covering 2025-03-07 to 2025-03-10. Get the full timeline:

Most recent: Clinical Trial Update: ATL001 in Patients With Advanced Unresectable or Metastatic NSCLC [Phase 1, Phase 2]